<VariationArchive VariationID="2857778" VariationName="NM_022132.5(MCCC2):c.735del (p.Leu246fs)" VariationType="Deletion" Accession="VCV002857778" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3021673" VariationID="2857778">
      <GeneList>
        <Gene Symbol="MCCC2" FullName="methylcrotonyl-CoA carboxylase subunit 2" GeneID="64087" HGNC_ID="HGNC:6937" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NW_025791777.1" start="2074427" stop="2098393" display_start="2074427" display_stop="2098393" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="71587340" stop="71658706" display_start="71587340" display_stop="71658706" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NT_187651.1" start="1117315" stop="1142082" display_start="1117315" display_stop="1142082" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NW_003315917.2" start="1585825" stop="1610592" display_start="1585825" display_stop="1610592" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="70883114" stop="70954530" display_start="70883114" display_stop="70954530" Strand="+" />
          </Location>
          <OMIM>609014</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_022132.5(MCCC2):c.735del (p.Leu246fs)</Name>
      <CanonicalSPDI>NC_000005.10:71626744:CCCCCC:CCCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="71626745" stop="71626745" display_start="71626745" display_stop="71626745" variantLength="1" positionVCF="71626744" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="70922572" stop="70922572" display_start="70922572" display_stop="70922572" variantLength="1" positionVCF="70922571" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>L246fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.71626750del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.71626750del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363147.1" sequenceAccession="NM_001363147" sequenceVersion="1" change="c.625-5371del">
            <Expression>NM_001363147.1:c.625-5371del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.70922577del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.70922577del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008882.1" sequenceAccession="NG_008882" sequenceVersion="1" change="g.44463del">
            <Expression>NG_008882.1:g.44463del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022132.5" sequenceAccession="NM_022132" sequenceVersion="5" change="c.735del" MANESelect="true">
            <Expression>NM_022132.5:c.735del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_071415.1" sequenceAccession="NP_071415" sequenceVersion="1" change="p.Leu246fs">
            <Expression>NP_071415.1:p.Leu246fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_022132.5(MCCC2):c.735del (p.Leu246fs) AND 3-methylcrotonyl-CoA carboxylase 2 deficiency" Accession="RCV003599901" Version="1">
        <ClassifiedConditionList TraitSetID="488">
          <ClassifiedCondition DB="MedGen" ID="C1859499">3-methylcrotonyl-CoA carboxylase 2 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-20" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11181649</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22642865</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="488" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">METHYLCROTONYLGLYCINURIA, TYPE II</ElementValue>
                <XRef Type="MIM" ID="210210" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">3 alpha methylcrotonyl-CoA carboxylase 2 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">3 alpha methylcrotonylglycinuria 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MCC 2 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Methylcrotonylglycinuria type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">3-methylcrotonyl-CoA carboxylase 2 deficiency</ElementValue>
                <XRef ID="MONDO:0008862" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MCC2D</ElementValue>
                <XRef Type="MIM" ID="210210" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9151" />
                <XRef ID="9151" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C5-OH Acylcarnitine, Organic Acidemias, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH-Elevated.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Organic Acidemias: Elevated C5-OH, 2022</CitationText>
              </Citation>
              <XRef ID="6" DB="Orphanet" />
              <XRef ID="C1859499" DB="MedGen" />
              <XRef ID="MONDO:0008862" DB="MONDO" />
              <XRef Type="MIM" ID="210210" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8246837" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="21546474|MedGen:C1859499" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004458095" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11181649</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22642865</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with MCCC2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu246Trpfs*27) in the MCCC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MCCC2 are known to be pathogenic (PMID: 11181649, 22642865).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MCCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.70922572del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1859499" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8246837" TraitType="Disease" MappingType="XRef" MappingValue="C1859499" MappingRef="MedGen">
        <MedGen CUI="C1859499" Name="3-methylcrotonyl-CoA carboxylase 2 deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

